It has been shown in colorectal cancer that NLRP3 activation can enhance antitumor immunity by promoting NK cell activity and IL-18/IFN-γ signaling, whereas microbiota-driven dysregulation of NLRP3/GSDMD may instead support tumorigenesis through disrupted signaling [281]. Here, NLRP3 is linked to colorectal cancer.